Medneo UK has announced the acquisition of Fairford Medical's fleet of MRI and CT scanners, a move that strengthens its ability to support the NHS in addressing rising demand for diagnostic imaging services.
The transaction marks medneo's first acquisition since being backed by CVC DIF, the infrastructure strategy of leading global private markets manager CVC in August 2024. It also represents the first stage in an ambitious programme of expansion for medneo, which is focused on delivering high-quality, patient-centred diagnostic services across the UK.
For medneo, this transaction represents the beginning of a long-term expansion strategy, underpinned by investment in technology, people, and partnerships.
By integrating Fairford Medical's fleet, medneo will increase its national footprint and add much-needed capacity, helping to reduce waiting times and improve patient access to essential diagnostic care.
Ella Tracey, CEO of medneo UK, said: "This is a significant step forward in increasing our capacity to support the NHS in diagnostics over the coming year. We are looking forward to staffing these units and delivering our usual high standards of care to patients. This is the first of many steps in medneo's UK growth story."
Neil Marvell, Managing Director at CVC DIF, said: "We are delighted to support medneo in this first strategic acquisition. Expanding diagnostic capacity is critical for the NHS, and this investment is an important milestone in medneo's ambitious growth plans for the UK."
Michael Bradfield, Chairman of Fairford Medical, commented: "We know that medneo will continue to provide an exemplary service to the trusts we are currently working with. This opportunity has come at the right time and I can't wait to see what the future holds for medneo."
